Effects of combination anti-vascular endothelial growth factor receptor and anti-epidermal growth factor receptor therapies on the growth of gastric cancer in a nude mouse model

By Jung Y.D.   Mansfield P.F.   Akagi M.   Takeda A.   Liu W.   Bucana C.D.   Hicklin D.J.   Ellis L.M.  

European Journal of Cancer, Vol. 38, Iss. 8, 2002-05 ,pp. : 1133-1140

Elsevier

Access to resources Recommend Favorite

Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2

By                    

Oncology Reports, Vol. 28, Iss. 5, 2012-01 ,pp. : 1799-1807

Spandidos Publications

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I/II study of S-1 plus cisplatin combined with peptide vaccines for human vascular endothelial growth factor receptor 1 and 2 in patients with advanced gastric cancer

By                                

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1297-1304

Spandidos Publications

Access to resources Recommend Favorite

T cells are crucial for the anti-metastatic effect of anti-epidermal growth factor receptor antibodies

By Garrido Greta   Lorenzano Pablo   Sánchez Belinda   Beausoleil Irene   Alonso Daniel   Pérez Rolando   Fernández Luis  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1701-1710

Springer Publishing Company

Access to resources Recommend Favorite